ConforMIS Begins Limited Release Of Patient-Specific Knee
This article was originally published in The Gray Sheet
Executive SummaryConforMIS is pursuing a limited release of its iTotal CR patient-specific total knee replacement system to get detailed feedback from surgeons on the implant procedure, which the company says involves fewer steps than with standard total knee implants. ConforMIS announced receipt of 510(k) clearance Feb. 3.
You may also be interested in...
Medical device manufacturers have a growing interest in 3D printing, a technology that could upend the manufacturing and distribution of certain medical devices and expand the scope of personalized medicine – especially in orthopedics, where it's used for some models, implants, and surgical cutting guides. Despite uncertainties related to regulation, reimbursement, and scaling up, global 3D printing revenues for medical and dental applications reached an estimated $537.1 million in 2014.
Recent new product launches and approvals include Boston Scientific’s novel S-ICD subcutaneous implantable cardioverter defibrillator, Globus Medical’s Secure-C artificial cervical disc and ConforMIS’ next-generation iTotal G2 total knee replacement.
Consensus document issued on transcatheter heart valves. Boston Scientific launches Asia-Pacific organization. More news briefs.